Form 8-K Galena Biopharma, Inc. For: Nov 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
Roth Trims PT on Galena (GALE) Following Q3 Results, Plans to Spin Commercial Assets
November 10, 2015 9:18 AM ESTRoth Capital is trimming its price target on Buy-rated Galena Biopharma (Nasdaq: GALE) from $8 to $6 following Q3 results and plans to spin its commercial business, as... More



